Cargando…

Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study

BACKGROUND: The objectives of this pilot study were to evaluate treatment quality for the risk factors of hypertension, diabetes and hyperlipidemia as well as the overall treatment quality for patients on an internal nephrology ward. This evaluation included the collection of data concerning the qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Stemer, Gunar, Zehetmayer, Sonja, Lemmens-Gruber, Rosa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744655/
https://www.ncbi.nlm.nih.gov/pubmed/19732465
http://dx.doi.org/10.1186/1472-6904-9-15
_version_ 1782171908668653568
author Stemer, Gunar
Zehetmayer, Sonja
Lemmens-Gruber, Rosa
author_facet Stemer, Gunar
Zehetmayer, Sonja
Lemmens-Gruber, Rosa
author_sort Stemer, Gunar
collection PubMed
description BACKGROUND: The objectives of this pilot study were to evaluate treatment quality for the risk factors of hypertension, diabetes and hyperlipidemia as well as the overall treatment quality for patients on an internal nephrology ward. This evaluation included the collection of data concerning the quality of therapeutic drug monitoring, drug use and potential drug-drug interactions. Establishing such baseline information highlights areas that have a need for further therapeutic intervention and creates a foundation for improving patient care, a subject that could be addressed in future clinical pharmacy research projects. METHODS: Medical charts of patients treated on a single internal nephrology ward were retrospectively evaluated using a predefined data collection form. Assessment of further need for therapeutic intervention was performed. RESULTS: For 76.5% (n = 78) of the total study population (n = 102), there was either a possibility (39.2%, n = 40) or a need (37.3%, n = 38) for further intervention based on the overall assessment. For the risk factors of hypertension, diabetes and hyperlipidemia, the proportions of patients that require further intervention were 78.8% (n = 71), 90.6% (n = 58) and 87.9% (n = 58), respectively. Patients with diabetes or hyperlipidemia were less likely to have optimal risk factor control. The number of drugs prescribed and the number of potential drug-drug interactions were significantly higher after in-hospital treatment. CONCLUSION: Risk factor treatment needs optimisation. Risk factor management, systematic medication reviews, and screening for and management of potential drug-drug interactions deserve great attention. Clinical pharmacy services could help in the achievement of treatment goals.
format Text
id pubmed-2744655
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27446552009-09-16 Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study Stemer, Gunar Zehetmayer, Sonja Lemmens-Gruber, Rosa BMC Clin Pharmacol Research Article BACKGROUND: The objectives of this pilot study were to evaluate treatment quality for the risk factors of hypertension, diabetes and hyperlipidemia as well as the overall treatment quality for patients on an internal nephrology ward. This evaluation included the collection of data concerning the quality of therapeutic drug monitoring, drug use and potential drug-drug interactions. Establishing such baseline information highlights areas that have a need for further therapeutic intervention and creates a foundation for improving patient care, a subject that could be addressed in future clinical pharmacy research projects. METHODS: Medical charts of patients treated on a single internal nephrology ward were retrospectively evaluated using a predefined data collection form. Assessment of further need for therapeutic intervention was performed. RESULTS: For 76.5% (n = 78) of the total study population (n = 102), there was either a possibility (39.2%, n = 40) or a need (37.3%, n = 38) for further intervention based on the overall assessment. For the risk factors of hypertension, diabetes and hyperlipidemia, the proportions of patients that require further intervention were 78.8% (n = 71), 90.6% (n = 58) and 87.9% (n = 58), respectively. Patients with diabetes or hyperlipidemia were less likely to have optimal risk factor control. The number of drugs prescribed and the number of potential drug-drug interactions were significantly higher after in-hospital treatment. CONCLUSION: Risk factor treatment needs optimisation. Risk factor management, systematic medication reviews, and screening for and management of potential drug-drug interactions deserve great attention. Clinical pharmacy services could help in the achievement of treatment goals. BioMed Central 2009-09-06 /pmc/articles/PMC2744655/ /pubmed/19732465 http://dx.doi.org/10.1186/1472-6904-9-15 Text en Copyright © 2009 Stemer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Stemer, Gunar
Zehetmayer, Sonja
Lemmens-Gruber, Rosa
Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
title Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
title_full Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
title_fullStr Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
title_full_unstemmed Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
title_short Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
title_sort evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744655/
https://www.ncbi.nlm.nih.gov/pubmed/19732465
http://dx.doi.org/10.1186/1472-6904-9-15
work_keys_str_mv AT stemergunar evaluationofriskfactormanagementofpatientstreatedonaninternalnephrologywardapilotstudy
AT zehetmayersonja evaluationofriskfactormanagementofpatientstreatedonaninternalnephrologywardapilotstudy
AT lemmensgruberrosa evaluationofriskfactormanagementofpatientstreatedonaninternalnephrologywardapilotstudy